NCT02308137View on ClinicalTrials.gov

Domperidone in Secondary Progressive Multiple Sclerosis (SPMS)

PHASE2CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

January 3, 2020

Study Completion Date

January 3, 2020

Conditions
Multiple Sclerosis, Secondary Progressive
Interventions
DRUG

Domperidone

Simon-2-stage design for domperidone futility

Trial Locations (1)

T2N 2T9

Calgary MS Clinic at Foothills Medical Centre, Calgary

Sponsors
All Listed Sponsors
collaborator

Alberta Innovates Health Solutions

OTHER

lead

University of Calgary

OTHER